go back

FLT3 Testing For Midostaurin Treatment

Kansas rates for HCPCS 0023U

Checks acute myeloid leukemia for changes in the FLT3 gene in order to decide whether the medicine midostaurin is appropriate. It reports which of three variant forms are present, tying the genetic result directly to that one drug.

Rates data updated June 2026.

Facilitymedian $437 · 10th–90th $174$7940%10%10th90th$437Professionalmedian $200 · 10th–90th $162$2510%10%20%10th90th$200$100.0$200.0$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$239.88
Median
$467.74
Typical High
$933.25
Aetna
Setting
Professional
Modifier
Global
Typical Low
$165.96
Median
$199.53
Typical High
$263.03
BCBS
Setting
Professional
Modifier
Global
Typical Low
$251.19
Median
$251.19
Typical High
$251.19
Cigna
Setting
Facility
Modifier
Global
Typical Low
$223.87
Median
$457.09
Typical High
$562.34
Medica
Setting
Facility
Modifier
Global
Typical Low
$199.53
Median
$251.19
Typical High
$331.13
Medica
Setting
Professional
Modifier
Global
Typical Low
$104.71
Median
$147.91
Typical High
$1,230.27
United
Setting
Facility
Modifier
Global
Typical Low
$104.71
Median
$251.19
Typical High
$295.12
United
Setting
Professional
Modifier
Global
Typical Low
$104.71
Median
$147.91
Typical High
$251.19